Holen Sie sich die Stockscreener-App
162.82
1.66%
-2.75
Handel nachbörslich:
163.70
0.88
+0.54%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LULU?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$165.57
Offen:
$165.16
24-Stunden-Volumen:
4.89M
Relative Volume:
1.52
Marktkapitalisierung:
$18.82B
Einnahmen:
$11.10B
Nettoeinkommen (Verlust:
$1.58B
KGV:
12.24
EPS:
13.2981
Netto-Cashflow:
$921.68M
1W Leistung:
+3.19%
1M Leistung:
-13.07%
6M Leistung:
-4.01%
1J Leistung:
-49.82%
1-Tages-Spanne:
$161.21
$166.69
1-Wochen-Bereich:
$156.79
$169.40
52-Wochen-Spanne:
$156.64
$348.50
Lululemon Athletica Inc Stock (LULU) Company Profile
Firmenname
Lululemon Athletica Inc
Sektor
Branche
Telefon
604-732-6124
Adresse
1818 CORNWALL AVENUE, VANCOUVER
Compare LULU vs TJX, ROST, BURL, GAP
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LULU
Lululemon Athletica Inc
|
162.82 | 18.82B | 11.10B | 1.58B | 921.68M | 13.30 |
TJX
Tjx Companies Inc
|
154.98 | 172.10B | 60.37B | 5.49B | 4.86B | 4.8738 |
ROST
Ross Stores Inc
|
211.19 | 68.31B | 22.75B | 2.15B | 2.21B | 6.6131 |
BURL
Burlington Stores Inc
|
310.38 | 19.53B | 11.57B | 610.15M | 171.59M | 9.5238 |
GAP
Gap Inc
|
23.91 | 8.89B | 15.37B | 816.00M | 823.00M | 2.1414 |
Lululemon Athletica Inc Stock (LULU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Bestätigt | Telsey Advisory Group | Market Perform |
| 2026-03-12 | Bestätigt | BTIG Research | Buy |
| 2026-01-08 | Eingeleitet | Deutsche Bank | Hold |
| 2025-12-12 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-12-12 | Bestätigt | Telsey Advisory Group | Market Perform |
| 2025-12-10 | Eingeleitet | Guggenheim | Neutral |
| 2025-10-20 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-10-16 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-09-25 | Herabstufung | Needham | Buy → Hold |
| 2025-09-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-09-11 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-09-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-09-05 | Bestätigt | Needham | Buy |
| 2025-09-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-09-05 | Herabstufung | Stifel | Buy → Hold |
| 2025-09-05 | Herabstufung | Telsey Advisory Group | Outperform → Market Perform |
| 2025-09-05 | Herabstufung | Truist | Buy → Hold |
| 2025-09-05 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-08-29 | Bestätigt | Needham | Buy |
| 2025-08-27 | Bestätigt | BTIG Research | Buy |
| 2025-07-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-06-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-01 | Herabstufung | Argus | Buy → Hold |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-03-28 | Bestätigt | Telsey Advisory Group | Outperform |
| 2025-03-26 | Bestätigt | Needham | Buy |
| 2025-01-14 | Bestätigt | Telsey Advisory Group | Outperform |
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2025-01-07 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-06 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-12-02 | Bestätigt | Jefferies | Underperform |
| 2024-11-22 | Eingeleitet | Needham | Hold |
| 2024-10-01 | Bestätigt | Morgan Stanley | Overweight |
| 2024-08-28 | Bestätigt | Wedbush | Outperform |
| 2024-08-26 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-08-23 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-08-22 | Bestätigt | Citigroup | Neutral |
| 2024-08-02 | Herabstufung | Goldman | Buy → Neutral |
| 2024-07-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-07-25 | Bestätigt | JP Morgan | Overweight |
| 2024-06-06 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-06-06 | Bestätigt | JP Morgan | Overweight |
| 2024-06-06 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-05-08 | Fortgesetzt | BTIG Research | Buy |
| 2024-04-29 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-04-04 | Bestätigt | Jefferies | Underperform |
| 2024-03-22 | Bestätigt | Needham | Buy |
| 2024-02-09 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2024-01-22 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-12-13 | Bestätigt | Telsey Advisory Group | Outperform |
| 2023-12-08 | Bestätigt | Needham | Buy |
| 2023-12-08 | Bestätigt | Telsey Advisory Group | Outperform |
| 2023-12-05 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-04 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-11-17 | Eingeleitet | Truist | Buy |
| 2023-11-07 | Eingeleitet | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | Needham | Buy |
| 2023-09-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-05 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-09-01 | Bestätigt | Oppenheimer | Outperform |
| 2023-09-01 | Bestätigt | Telsey Advisory Group | Outperform |
| 2023-07-25 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-04-20 | Bestätigt | BofA Securities | Buy |
| 2023-03-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-16 | Eingeleitet | Redburn | Sell |
| 2023-01-24 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2023-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-13 | Eingeleitet | Raymond James | Strong Buy |
| 2022-10-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-07-26 | Fortgesetzt | Piper Sandler | Neutral |
| 2022-07-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2022-06-06 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-05-26 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-29 | Eingeleitet | Wedbush | Outperform |
| 2022-04-19 | Hochstufung | Truist | Hold → Buy |
| 2022-03-15 | Eingeleitet | Bernstein | Underperform |
| 2022-01-12 | Bestätigt | Cowen | Outperform |
| 2021-12-16 | Eingeleitet | Truist | Hold |
| 2021-12-10 | Bestätigt | BTIG Research | Buy |
| 2021-12-10 | Bestätigt | Cowen | Outperform |
| 2021-12-10 | Bestätigt | Deutsche Bank | Buy |
| 2021-12-10 | Bestätigt | JP Morgan | Overweight |
| 2021-12-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-12-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-10 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-09-17 | Bestätigt | Oppenheimer | Outperform |
| 2021-09-10 | Bestätigt | Argus | Buy |
| 2021-09-10 | Bestätigt | Citigroup | Neutral |
| 2021-09-10 | Bestätigt | UBS | Neutral |
| 2021-09-09 | Bestätigt | BofA Securities | Buy |
| 2021-08-17 | Bestätigt | B. Riley Securities | Buy |
| 2021-07-14 | Eingeleitet | Goldman | Buy |
| 2021-04-23 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2020-12-09 | Bestätigt | Raymond James | Strong Buy |
| 2020-10-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-10-26 | Bestätigt | JP Morgan | Overweight |
| 2020-09-30 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-09-03 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-08-27 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-08-24 | Bestätigt | Susquehanna | Positive |
| 2020-06-12 | Bestätigt | MKM Partners | Buy |
| 2020-06-12 | Bestätigt | Needham | Buy |
| 2020-06-08 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-06-02 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-05-29 | Bestätigt | Raymond James | Strong Buy |
| 2020-05-19 | Bestätigt | B. Riley FBR | Buy |
| 2020-04-30 | Bestätigt | B. Riley FBR | Buy |
| 2020-04-29 | Eingeleitet | BTIG Research | Buy |
| 2020-04-03 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-03-24 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-03-23 | Hochstufung | Needham | Hold → Buy |
| 2020-03-20 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Lululemon Athletica Inc Aktie (LULU) Neueste Nachrichten
1 Incredible Value Stock Down 68% to Buy Now Before It Rebounds - The Globe and Mail
1 Incredible Value Stock Down 68% to Buy Now Before It Rebounds - The Motley Fool
What's going on with Lululemon Athletica stock Tuesday? - MSN
Is lululemon athletica inc. (LULU) A Good Stock To Buy Now? - Insider Monkey
Better Stock to Buy Right Now: Nike vs. Lululemon - AOL.com
Swiss Life Asset Management Ltd Has $7.91 Million Position in lululemon athletica inc. $LULU - MarketBeat
Lululemon's Strategy Amid CEO Vacancy and Margin Pressure | 2026 AnalysisNews and Statistics - IndexBox
Can Lululemon Stock Recover? - The Motley Fool
Lululemon's Performance Review and Future Outlook - Intellectia AI
Morgan Stanley Maintains Buy Rating on Lululemon Athletica (LULU) - MSN
lululemon athletica inc. stock outperforms competitors despite losses on the day - MarketWatch
Lululemon’s Strong Quarter Can’t Hide A Slowing Growth Story - Trefis
Lululemon (NASDAQ: LULU) Reports Q4 FY2025 Results - Value The Markets
How Cautious 2026 Guidance and Leadership Changes At lululemon athletica (LULU) Have Changed Its Investment Story - simplywall.st
Lululemon Athletica Inc. (LULU): High-Quality Consumer Brand Trading Near Intrinsic Value - The Acquirer's Multiple
Lululemon (LULU) Aims to Revive Sales Amidst Stiff Competition - GuruFocus
SA Asks: What does lululemon need to do to revive sales? (LULU:NASDAQ) - Seeking Alpha
Should investors buy Lululemon stock? - MSN
Should Investors Buy Lululemon Stock? - The Globe and Mail
Lululemon's Performance: Stock Downturn, Leadership Search, and Q4 2025 AnalysisNews and Statistics - IndexBox
Down 68%, This Growth Stock Looks Oversold. Is It a Buy? - The Motley Fool
Lululemon (LULU) Founder Chip Wilson Is Still Unhappy After Board Changes: ‘Deficiencies Remain’ - TipRanks
Lululemon Athletica Inc. (NASDAQ:LULU) Passes Key Peter Lynch Investment Criteria - ChartMill
Lululemon Athletica Inc. (NASDAQ:LULU) Q4 2025 Earnings Call Transcript - Insider Monkey
Lululemon's Modest Growth Amid CEO Vacancy Raises Concerns - Intellectia AI
Jefferies Maintains Hold on LULU (Lululemon Athletica Inc.) March 2026 - Meyka
Lululemon stock sinks despite earnings beat - MSN
lululemon athletica Q4 Earnings Call Highlights - Yahoo Finance
LULU Stock Quote Price and Forecast - CNN
Lululemon Q4 Earnings Beat Offsets Weak Forecast, Stock Rises | March 2026News and Statistics - IndexBox
Lululemon faces weakening sales as product missteps, proxy battle weigh - eMarketer
Lululemon faces growth headwinds despite China strength; CEO plan weighs on analysts - Yahoo Finance
Lululemon forecasts weaker 2026 sales, says 'more work to be done' - Financial Post
Lululemon founder Chip Wilson says 'deficiencies remain' even after board shakeup - Castanet
Lululemon Athletica Pops 5%: Board Shakeup and Earnings Beat Lift the Stock in a Falling Market - AOL.com
lululemon's recovery takes shape but company not yet out of the woods -- analysts (LULU:NASDAQ) - Seeking Alpha
lululemon (LULU) Q4 2025 Financial Results Conference Call Transcript - Bitget
lululemon athletica (NASDAQ:LULU) Price Target Lowered to $170.00 at Truist Financial - MarketBeat
EXEC: Lululemon’s Co-CEOs Outline U.S. Return to Full-Price Growth - SGB Media Online
Lululemon Athletica Inc (LULU) Trading 3.56% Higher on Mar 18 - GuruFocus
These Analysts Slash Their Forecasts On Lululemon Following Q4 Earnings - Benzinga
Lululemon tops Street as CEO search continues; adds former Levi’s CEO to board - Chain Store Age
lululemon Q4 Earnings & Revenues Beat, Margin Pressures Persist - TradingView
JPMorgan Chase & Co. Cuts lululemon athletica (NASDAQ:LULU) Price Target to $196.00 - MarketBeat
What's Going On With Lululemon Stock Today? - Benzinga
Lululemon Says It Wants To Sell More Clothes at Full Price. Its Stock Is Climbing. - Investopedia
Is trending stock Lululemon Athletica Inc. (LULU) a buy now? - MSN
Lululemon Q4 2025 Earnings: Executives Discuss Results and 2026 StrategyNews and Statistics - IndexBox
Lululemon founder Chip Wilson says ‘deficiencies remain’ even after board shakeup - The Spec
Lululemon Leaders Hold Firm in Proxy Battle with Founder Chip Wilson, Appoint Former Levi’s CEO Chip Bergh to Board - Retail TouchPoints
lululemon athletica inc. 2025 Annual Report: Global Business Overview, Market Segments, and Growth Strategies - Minichart
Finanzdaten der Lululemon Athletica Inc-Aktie (LULU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):